BR112012025044A2 - método para conservar adjuvantes de alum e vacinas com adjuvantes de alum - Google Patents
método para conservar adjuvantes de alum e vacinas com adjuvantes de alumInfo
- Publication number
- BR112012025044A2 BR112012025044A2 BR112012025044A BR112012025044A BR112012025044A2 BR 112012025044 A2 BR112012025044 A2 BR 112012025044A2 BR 112012025044 A BR112012025044 A BR 112012025044A BR 112012025044 A BR112012025044 A BR 112012025044A BR 112012025044 A2 BR112012025044 A2 BR 112012025044A2
- Authority
- BR
- Brazil
- Prior art keywords
- alum
- preserving
- adjuvants
- adjuvanted vaccines
- vaccines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
método para conservar adjuvantes de alum e vacinas com adjuvantes de alum. método para conservar um adjuvante de sal alumínio durante o congelamento ou secagem compreendendo o congelamento ou secagem de uma suspensão ou solução aquosa compreendendo: (a) um adjuvante de sal alumínio; (b) um composto da fórmula (i) ou uma sal ou éster fisiologicamente aceitável do mesmo ou um composto da fórmula (ii) ou um sal ou éster fisiolagicamente aceitável do mesmo; e (c) opcionalmente, um ou mais açúcares.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1005522.6A GB201005522D0 (en) | 2010-03-31 | 2010-03-31 | Method for preserving alum-adjuvanted vaccines |
GBGB1005518.4A GB201005518D0 (en) | 2010-03-31 | 2010-03-31 | Preservation of alum-adjuvanted vaccines |
PCT/GB2011/000497 WO2011121305A2 (en) | 2010-03-31 | 2011-03-31 | Method for preserving alum adjuvants and alum-adjuvanted vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012025044A2 true BR112012025044A2 (pt) | 2016-06-21 |
Family
ID=43971221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012025044A BR112012025044A2 (pt) | 2010-03-31 | 2011-03-31 | método para conservar adjuvantes de alum e vacinas com adjuvantes de alum |
Country Status (13)
Country | Link |
---|---|
US (1) | US9101607B2 (pt) |
EP (1) | EP2552410B1 (pt) |
JP (1) | JP6023696B2 (pt) |
KR (1) | KR101819250B1 (pt) |
CN (1) | CN102892409B (pt) |
AU (1) | AU2011234268B2 (pt) |
BR (1) | BR112012025044A2 (pt) |
CA (1) | CA2795050C (pt) |
DK (1) | DK2552410T3 (pt) |
ES (1) | ES2708989T3 (pt) |
GB (1) | GB2499480A (pt) |
HU (1) | HUE042330T2 (pt) |
WO (1) | WO2011121305A2 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011234264B2 (en) | 2010-03-31 | 2016-02-04 | Stabilitech Ltd | Excipients for stabilising viral particles, polypeptides or biological material |
DK2898890T3 (da) | 2010-03-31 | 2019-11-25 | Stabilitech Biopharma Ltd | Stabilisering af viruspartikler |
GB201117233D0 (en) | 2011-10-05 | 2011-11-16 | Stabilitech Ltd | Stabilisation of polypeptides |
US9588123B2 (en) * | 2014-04-11 | 2017-03-07 | Surmodics Ivd, Inc. | Compositions and methods for in vitro diagnostic tests including zwitterionic solubilization reagent |
GB201406569D0 (en) * | 2014-04-11 | 2014-05-28 | Stabilitech Ltd | Vaccine compositions |
GB2562241B (en) | 2017-05-08 | 2022-04-06 | Stabilitech Biopharma Ltd | Vaccine compositions |
AR111760A1 (es) | 2017-05-19 | 2019-08-14 | Novartis Ag | Compuestos y composiciones para el tratamiento de tumores sólidos mediante administración intratumoral |
CN113750228B (zh) * | 2021-09-25 | 2024-02-20 | 大连理工大学 | 一种冷冻保护剂在铝佐剂中的应用 |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3927208A (en) | 1973-05-14 | 1975-12-16 | Rit Rech Ind Therapeut | Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them |
US4631189A (en) | 1980-03-10 | 1986-12-23 | Da Vinci Laboratories, a division of FoodScience Corporation | N,N-dimethylglycine and use in immune response |
JPS6013718A (ja) * | 1983-07-05 | 1985-01-24 | Chemo Sero Therapeut Res Inst | B型肝炎ワクチン |
JPS60193925A (ja) * | 1984-03-13 | 1985-10-02 | Chemo Sero Therapeut Res Inst | 凍結乾燥製剤化ワクチン |
US4808700A (en) | 1984-07-09 | 1989-02-28 | Praxis Biologics, Inc. | Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers |
JPS61189228A (ja) | 1985-02-19 | 1986-08-22 | Nippon Sekijiyuujishiya | 血液凝固第8因子製剤の製法 |
US4950596A (en) | 1985-03-04 | 1990-08-21 | The Dow Chemical Company | Stabilization of intracellular enzymes |
JPS6238173A (ja) | 1985-08-13 | 1987-02-19 | 三菱レイヨン株式会社 | 抗血液凝固剤 |
US5169758A (en) | 1986-05-02 | 1992-12-08 | Boehringer Mannheim Gmbh | Stabilized, NAD(P)H-dependent, soluble nitrate reductase, a process for the preparation thereof and a reagent containing it |
NZ221306A (en) | 1986-08-15 | 1990-02-26 | Commw Scient Ind Res Org | 2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof |
EP0303746B2 (en) * | 1987-08-21 | 1998-12-02 | Mallinckrodt Group Inc. | Stabilization of growth promoting hormones |
GB8826429D0 (en) | 1988-11-11 | 1988-12-14 | Univ Leeds Ind Service Ltd | Enzyme stabilisation systems |
CA2065023A1 (en) | 1989-08-15 | 1991-02-16 | Brent Dorval | Stabilized vaccine compositions |
CA2051092C (en) | 1990-09-12 | 2002-07-23 | Stephen A. Livesey | Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions |
ZA936095B (en) | 1992-08-21 | 1994-03-14 | Univ Melbourne | Cytokine applications. |
WO1995011700A1 (en) | 1993-10-29 | 1995-05-04 | Pharmos Corp. | Submicron emulsions as vaccine adjuvants |
CN1151842C (zh) | 1995-07-27 | 2004-06-02 | 基因技术股份有限公司 | 稳定等渗的冻干蛋白制剂 |
GB9521806D0 (en) | 1995-10-25 | 1996-01-03 | Cortecs Ltd | Preservation methods |
FR2746109B1 (fr) | 1996-03-12 | 1998-04-17 | Rhone Poulenc Rorer Sa | Milieu pour la conservation de materiel biologique |
AU707186B2 (en) | 1997-07-01 | 1999-07-01 | Transgene S.A. | Compositions useful for transferring therapeutically active substances into a target cell, and their use in gene therapy |
CA2312233A1 (en) | 1997-11-26 | 1999-06-03 | Universal Preservation Technologies, Inc. | Preservation of sensitive biological samples by vitrification |
DK1133316T3 (da) | 1998-11-16 | 2009-05-25 | Introgen Therapeutics Inc | Adenovirus-formulering til genterapi |
US6689600B1 (en) | 1998-11-16 | 2004-02-10 | Introgen Therapeutics, Inc. | Formulation of adenovirus for gene therapy |
AUPQ347199A0 (en) | 1999-10-15 | 1999-11-11 | Csl Limited | Novel polypeptide fragments |
BR0111494A (pt) * | 2000-06-08 | 2004-01-13 | Powderject Vaccines Inc | Pó de livre escoamento formador de gel adequado para uso como uma vacina, processo para a preparação do mesmo, receptáculo de dosagem para uma seringa sem agulha, seringa sem agulha, composição de vacina, método para vacinação de um indivìduo, pó adequado para uso como uma vacina, e, processo para a preparação do mesmo |
DE10041515A1 (de) | 2000-08-24 | 2002-03-14 | Gerold Schuler | Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen |
US20040110267A1 (en) | 2000-12-15 | 2004-06-10 | Stratagene | Room temperature stable competent cells |
WO2002101412A2 (en) | 2001-06-08 | 2002-12-19 | Powderject Vaccines, Inc. | Spray freeze-dried compositions |
US7101693B2 (en) | 2001-09-07 | 2006-09-05 | Brigham Young University | Plasticized hydrophilic glasses for improved stabilization of biological agents |
JP4936618B2 (ja) | 2001-09-21 | 2012-05-23 | 株式会社ノエビア | 微細エマルション組成物 |
US20040161776A1 (en) * | 2001-10-23 | 2004-08-19 | Maddon Paul J. | PSMA formulations and uses thereof |
EP3210624A1 (en) | 2002-02-27 | 2017-08-30 | Immunex Corporation | Stabilized tnfr-fc composition comprising arginine |
EP1539244A1 (en) | 2002-06-27 | 2005-06-15 | Novo Nordisk A/S | Use of dimethyl sulfone as isotonicity agent |
WO2004007537A2 (en) | 2002-07-10 | 2004-01-22 | Transgene S.A. | Modified adenoviral fiber with ablated to cellular receptors |
AU2003272174A1 (en) | 2002-10-21 | 2004-05-04 | Biotage Ab | Use of osmolytes to heat stabilise luciferase and/or apyrase |
EP1578305A4 (en) | 2002-12-10 | 2008-08-27 | Schering Plough Ltd | DOG RANKL AND MANUFACTURING AND USE METHOD THEREFOR |
US20060247167A1 (en) | 2003-09-01 | 2006-11-02 | Novo Nordisk A/S | Stable formulations of peptides |
US7642077B2 (en) | 2003-12-08 | 2010-01-05 | Genencor International, Inc. | Biocomposite comprising co-precipitate of enzyme, silicate and polyamine |
US20070111211A1 (en) | 2003-12-30 | 2007-05-17 | Virumar Pituach Tarkivim Ltd. | Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof |
US8092788B2 (en) | 2004-03-03 | 2012-01-10 | Revance Therapeutics, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
US20060058238A1 (en) | 2004-09-15 | 2006-03-16 | Lee Laurent-Applegate | Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same |
BRPI0516830A (pt) | 2004-10-01 | 2008-09-23 | Ramscor Inc | composições de droga de liberação sustentada convenientemente implantáveis |
MX2007009091A (es) | 2005-01-28 | 2008-01-11 | Wyeth Corp | Formulaciones de polipeptido liquidas estabilizadas. |
GB0502661D0 (en) | 2005-02-09 | 2005-03-16 | Stabilitech Ltd | A desiccated product |
TWI398272B (zh) | 2005-03-08 | 2013-06-11 | Intervet Int Bv | 化學定義的安定劑 |
WO2006127150A2 (en) | 2005-04-08 | 2006-11-30 | Argos Therapeutics, Inc. | Dendritic cell compositions and methods |
AU2006299310A1 (en) | 2005-10-04 | 2007-04-12 | Alk-Abello A/S | Solid vaccine formulation |
KR101357685B1 (ko) | 2005-11-21 | 2014-02-06 | 사노피 파스퇴르 리미티드 / 사노피 파스퇴르 리미떼 | 재조합 바이러스용 안정화 제형 |
ES2352855T3 (es) | 2005-11-30 | 2011-02-23 | International Institute Of Cancer Immunology, Inc. | Nuevos compuestos peptídicos del tumor de wilms. |
EP1954252B1 (en) | 2005-12-02 | 2016-02-03 | GlaxoSmithKline Biologicals SA | Nanoparticles for use in immunogenic compositions |
EP1987067A4 (en) | 2006-02-15 | 2012-01-25 | Imclone Llc | ANTIBODY FORMULATION |
ES2286951B1 (es) * | 2006-05-26 | 2008-10-01 | Instituto Cientifico Y Tecnologico De Navarra, S.A | Nanoparticulas bioadhesivas para la administracion de moleculas biologicamente activas. |
NZ576563A (en) | 2006-11-03 | 2012-09-28 | Alphavax Inc | Alphavirus and alphavirus replicon particle formulations and methods |
GB0705245D0 (en) | 2007-03-19 | 2007-04-25 | Stabilitech Ltd | Stable biological products |
EP2131857B1 (en) * | 2007-03-22 | 2015-07-29 | The Regents of the University of Colorado, a body corporate | Method of preparing an immunologically-active adjuvant-bound dried vaccine composition |
WO2008150479A2 (en) * | 2007-06-01 | 2008-12-11 | Acologix, Inc. | High temperature stable peptide formulation |
WO2009015343A2 (en) * | 2007-07-25 | 2009-01-29 | Bioe, Inc. | Differentiation of multi-lineage progenitor cells to chondrocytes |
US20090123436A1 (en) | 2007-11-08 | 2009-05-14 | Surmodics, Inc. | Cryopreservative compositions and methods |
GB2479069B (en) | 2008-09-24 | 2012-07-25 | Stabilitech Ltd | Method for preserving polypeptides using a sugar and polyethyleneimine |
US20110212127A1 (en) | 2008-09-24 | 2011-09-01 | Stabilitech Ltd. | Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine |
CN101670104A (zh) | 2009-09-24 | 2010-03-17 | 浙江大学 | 一种含人参皂甙的油佐剂及其制备方法 |
DK2898890T3 (da) | 2010-03-31 | 2019-11-25 | Stabilitech Biopharma Ltd | Stabilisering af viruspartikler |
-
2011
- 2011-03-31 ES ES11712653T patent/ES2708989T3/es active Active
- 2011-03-31 WO PCT/GB2011/000497 patent/WO2011121305A2/en active Application Filing
- 2011-03-31 CN CN201180014386.6A patent/CN102892409B/zh active Active
- 2011-03-31 GB GB1216472.9A patent/GB2499480A/en not_active Withdrawn
- 2011-03-31 KR KR1020127028370A patent/KR101819250B1/ko active IP Right Grant
- 2011-03-31 JP JP2013501932A patent/JP6023696B2/ja active Active
- 2011-03-31 CA CA2795050A patent/CA2795050C/en active Active
- 2011-03-31 EP EP11712653.2A patent/EP2552410B1/en active Active
- 2011-03-31 DK DK11712653.2T patent/DK2552410T3/en active
- 2011-03-31 AU AU2011234268A patent/AU2011234268B2/en active Active
- 2011-03-31 BR BR112012025044A patent/BR112012025044A2/pt not_active Application Discontinuation
- 2011-03-31 HU HUE11712653A patent/HUE042330T2/hu unknown
- 2011-03-31 US US13/637,828 patent/US9101607B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20130156797A1 (en) | 2013-06-20 |
EP2552410B1 (en) | 2018-10-24 |
CA2795050C (en) | 2018-05-22 |
GB201216472D0 (en) | 2012-10-31 |
CN102892409B (zh) | 2015-12-09 |
WO2011121305A2 (en) | 2011-10-06 |
KR101819250B1 (ko) | 2018-01-16 |
EP2552410A2 (en) | 2013-02-06 |
CA2795050A1 (en) | 2011-10-06 |
AU2011234268A1 (en) | 2012-09-27 |
WO2011121305A3 (en) | 2011-11-24 |
HUE042330T2 (hu) | 2019-06-28 |
US9101607B2 (en) | 2015-08-11 |
KR20130012956A (ko) | 2013-02-05 |
DK2552410T3 (en) | 2019-02-18 |
JP6023696B2 (ja) | 2016-11-09 |
JP2013523705A (ja) | 2013-06-17 |
ES2708989T3 (es) | 2019-04-12 |
AU2011234268B2 (en) | 2015-07-02 |
CN102892409A (zh) | 2013-01-23 |
GB2499480A (en) | 2013-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012025044A2 (pt) | método para conservar adjuvantes de alum e vacinas com adjuvantes de alum | |
CY1121928T1 (el) | Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης | |
EA201592055A1 (ru) | 11-гидроксилпроизводные желчных кислот и их аминокислотные конъюгаты в качестве модуляторов фарнезоидных х-рецепторов | |
GB2499479A (en) | Stabilisation of viral particles | |
BR112016006326A2 (pt) | formulação seca de uma vacina, uso de uma formulação seca, método para fabricação de uma formulação seca, e, vacina | |
EA201300989A1 (ru) | Водная фармацевтическая композиция тапентадола для перорального введения | |
ES2488407T3 (es) | Preparación farmacéutica que contiene lipasa de origen bacteriano | |
AR106141A1 (es) | Métodos e intermediarios para la preparación de derivados de ácidos biliares | |
CL2012001298A1 (es) | Compuestos derivados del acido carbomoil-metilamino acetico sustituido, inhibidores de nep; composicion farmaceutica; combinacion farmaceutica; y uso para el tratamiento de hipertension arterial, hipertension pulmonar, insuficiencia cardiaca, entre otras. | |
EA201491548A1 (ru) | 2'-замещенные карбануклеозидные аналоги для противовирусного лечения | |
EA201790997A1 (ru) | Композиции гликопептидов | |
UA105229C2 (uk) | Фармацевтичний склад | |
EA201391515A1 (ru) | Инактивированная вакцина вируса денге | |
EA201170983A1 (ru) | Производные тиадиазолов и оксадиазолов, их получение и их применение в терапии | |
BR112015004515A2 (pt) | composição imunogênica | |
CR20150310A (es) | Solución para preservar conductos vasculares | |
GB2539148A (en) | Vaccine compositions | |
EA201690859A1 (ru) | Предотвращение инфекций, вызываемых staphylococcus aureus, гликопротеиновыми вакцинами, синтезированными в escherichia coli | |
EA201200786A1 (ru) | Комбинированная композиция, содержащая в качестве активного ингредиента l-карнитин или пропионил-l-карнитин, для предотвращения или лечения хронической венозной недостаточности | |
GB201117233D0 (en) | Stabilisation of polypeptides | |
CL2013000513A1 (es) | Uso de una composicion farmaceutica que comprende: a) un compuesto monohidratado formado por dos aniones y un cation o b) valsartan y un etil-ester de acido, para el tratamiento de hipertension y/o la prevencion o el tratamiento de insuficiencia cardiaca en un mamifero que recibe terapia anti-coagulante. | |
EA201590041A1 (ru) | Твердая форма холиновой соли вемурафениба | |
UY32414A (es) | Nuevos metodos | |
EA201491288A1 (ru) | ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ, СОДЕРЖАЩИЙ БРЕКСПИПРАЗОЛ И ЗАМЕЩЕННЫЙ β-ЦИКЛОДЕКСТРИН | |
DK3737470T3 (da) | 3-phenyl-4-hexynsyrederivater som gpr40-agonister |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |